Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-846-9 | CAS number: 12036-35-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Haferkorn (2018) is a GLP compliant study assessing the acute oral toxicity of dirhodium trioxide according OECD 425. No mortality or pathological changes were apparent at the limit dose of 2000 mg/kg bw following the 14-day observation period while growth was unaffected. It was concluded that dirhodium trioxide does not require classification for acute oral toxicity according to EU CLP criteria (EC 1272/2008).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 28 September 2018 - 31 October 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- up-and-down procedure
- Limit test:
- yes
- Specific details on test material used for the study:
- 100% Rh2O3x0.67 H2O or 95.5% Rh2O3 (based on Rh content of 77.4 wt%)
- Species:
- rat
- Strain:
- other: Crl: CD(SD)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH, Sandhofer Weg 7, 97633 Sulzfeld, Germany
- Females (if applicable) nulliparous and non-pregnant: No data
- Age at study initiation: approximately 8 weeks
- Weight at study initiation: 183-200 g
- Fasting period before study: 16 hours
- Housing: Individually in MAKROLON cages (type III plus) with granulated textured wood bedding material
- Diet (e.g. ad libitum): Commercial diet, ssniff® R/M-H V1534 (ssniff Spezialdiäten GmbH, 59494 Soest, Germany); discontinued approximately 16 hours before administration, food was withheld 3 - 4 hours post dosing.
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C ± 3
- Humidity (%): relative humidity 55 ± 10%
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12/12, 150 lux at approx 1.5m room height)
IN-LIFE DATES: From: 28 September 2018 to 31 October 2018 - Route of administration:
- oral: gavage
- Vehicle:
- propylene glycol
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL
- Amount of vehicle (if gavage): 10 mL/kg bw
- Justification for choice of vehicle: solubility of dirhodium trioxide in suitable vehicles was assessed in a preliminary solubility test. The test item was insoluble in 0.8% aqueous hydroxypropyl methylcellulose (Methocel) and sesame oil, but formed a suspension in propylene glycol, which was considered acceptable for oral dosing.
- Lot/batch no. (if required): Batch no. MKBX0067V, SIGMA-ALDRICH Chemie GmbH, 82024 Taufkirchen, Germany
- Purity: No data
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw - Doses:
- 2000 mg dirhodium trioxide/kg bw (limit dose)
- No. of animals per sex per dose:
- 5 (A dose of 2000 mg dirhodium trioxide/kg b.w. was tested in 1 animal. As the animal survived, the test item was administered to additional 4 animals)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Following dose administration, observations were made and recorded systematically with individual records being maintained for each animal. Clinical observations were recorded before and after dose administration: at 5, 15, 30 and 60 min, as well as 3, 6 and 24 hours after administration and then daily for a period of 14 days. During the follow-up period (two weeks), changes of skin and fur, eyes and mucous membranes, respiratory and circulatory function, autonomic and central nervous system and somatomotor activity as well as behaviour pattern were observed at least once a day until all symptoms subsided, thereafter each working day. Attention was also paid to possible tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
Observations on mortality were made at least once daily to minimize loss of animals during the study.
Individual body weights were recorded before administration of the test item (day 1) and thereafter and on days 2, 4 and 8 and prior to sacrifice on day 15. Changes in weight were calculated if survival exceeds one day.
- Necropsy of survivors performed: yes (macroscopic)
- Other examinations performed: No histopathology was carried out as no macroscopic findings were noted at necropsy. - Statistics:
- No statistical analysis was performed as the LD50 is greater than 2000 mg/kg b.w. and no main test was carried out.
- Preliminary study:
- The LD50 was greater than 2000 mg/kg bw therefore no main test was carried out.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No statistical analysis was performed as the LD50 is greater than 2000 mg/kg b.w. and no main test was carried out.
- Mortality:
- No animal died prematurely.
- Clinical signs:
- other: There were no clinical signs of toxicity.
- Gross pathology:
- No pathological findings were noted at necropsy.
- Other findings:
- Not applicable
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In an OECD guideline study, conducted to GLP, the acute oral LD50 of dirhodium trioxide was found to exceed 2000 mg/kg bw in female rats.
- Executive summary:
The acute oral toxicity of dirhodium trioxide was assessed in female rats, in a study conducted according to OECD Test Guideline 425 and to GLP.
Initially, one female received a single (limit) dose of 2000 mg/kg bw by oral gavage. As the animal survived, the test item was administered to an additional four animals. No mortality or pathological changes were apparent at the limit dose following the 14-day observation period while growth was unaffected. The study authors conclude that the acute oral median lethal dose (LD50) of the test material in females rats exceeds 2000 mg/kg bw.
Based on the results of this study, dirhodium trioxide does not require classification for acute oral toxicity according to EU CLP criteria (EC 1272/2008).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Dirhodium trioxide does not require classification for acute oral toxicity according to EU CLP criteria (EC 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.